# Harvard Bioscience Inc: Form 8-K, filed Apr 10, 2025

- Company: [Harvard Bioscience Inc](/companies/hbio.md) (CIK 1123494)
- Form: 8-K
- Filed: 2025-04-10
- Accepted by EDGAR: Apr 10, 2025, 16:46 ET
- Period: 2025-04-10
- Accession: 0001171843-25-002149
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1123494/000117184325002149/f8k_041025.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1123494/000117184325002149/

## Items reported

- Item 3.01: Delisting notice
- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1123494/000117184325002149/f8k_041025.htm

Filed Apr 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001171843-25-002149. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.